SWK Holdings Corp (OQ:SWKH)

Mar 21, 2024 07:00 am ET
SWK Holdings Corporation Announces Financial Results for Fourth Quarter 2023
Conference Call and Live Audio Webcast Scheduled for Thursday, March 21, 2024, at 10:00 a.m. ET
Nov 09, 2023 06:30 am ET
SWK Holdings Corporation Announces Financial Results for Third Quarter 2023
Conference Call and Live Audio Webcast Scheduled for Thursday, November 9, 2023, at 10:00 a.m. ET
Nov 06, 2023 03:05 pm ET
SWK Holdings Corporation to Report Third Quarter 2023 Financial Results
Conference Call and Live Audio Webcast Scheduled for Thursday, November 9, 2023, at 10:00 a.m. ET
Oct 30, 2023 08:00 am ET
SWK Holdings Corporation Announces B. Riley Securities Exercises Option to Purchase Approximately $3 Million in Additional Unsecured Senior Notes
DALLAS, Oct. 30, 2023 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ: SWKH) ("SWK" or the "Company") today announced that B. Riley Securities has exercised its option to purchase $2,968,750 in additional unsecured Senior notes (the "Notes") from its previously announced registered underwritten public offering (the "Offering") of $30.0 million in aggregate principal amount of 9.00% Senior notes due 2027. The total net proceeds are now approximately $31.9 million (after deducting underwriting discounts and commissions, but before other fees and estimated expenses). 
Oct 18, 2023 08:00 am ET
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
DALLAS, Oct. 18, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided a corporate progress update as well as a summary of the achievements of its borrower partners. 
Oct 11, 2023 08:00 am ET
SWK Holdings Corporation Increases Revolving Credit Facility to $60 Million
DALLAS, Oct. 11, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life-science-focused, specialty finance company catering to small- and mid-sized commercial-stage companies, today announced an amendment to its revolving credit facility. The amended credit facility provides total commitments of $60 million, including a new $15 million commitment from Woodforest National Bank ("Woodforest") and an existing $45 million commitment from First Horizon Bank. All other terms of the facility remain unchanged, including the accordion feature, which provides for
Oct 03, 2023 04:05 pm ET
SWK Holdings Corporation Announces Closing of Public Offering of Senior Unsecured Notes Due 2027
DALLAS, Oct. 3, 2023 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ: SWKH) ("SWK" or the "Company") today announced that it has completed its previously announced registered underwritten public offering (the "Offering") of $30 million in aggregate principal amount of 9.00% Senior notes due 2027 (the "Notes"). SWK has also granted the underwriters of the Offering an option to purchase up to an additional $4.5 million in aggregate principal amount of the Notes. The total net proceeds from the Offering (excluding exercise of the underwriter option) are approximately $29.1 million (after deduc
Sep 28, 2023 06:34 pm ET
SWK Holdings Corporation Announces Pricing of Public Offering of Senior Unsecured Notes Due 2027
DALLAS, Sept. 28, 2023 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ: SWKH) ("SWK" or the "Company") today announced that it has priced its previously announced registered underwritten public offering (the "Offering") of $30 million in aggregate principal amount of 9.00% Senior notes due 2027 (the "Notes"). SWK has also granted the underwriters of the Offering an option to purchase up to an additional $4.5 million in aggregate principal amount of the Notes. The total net proceeds from the Offering (excluding exercise of the underwriter option) are approximately $29.1 million (after deduct
Sep 26, 2023 04:07 pm ET
SWK Holdings Corporation Announces Public Offering of Senior Unsecured Notes Due 2028
DALLAS, Sept. 26, 2023 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ: SWKH) ("SWK" or the "Company") today announced that it plans to offer $30 million in aggregate principal amount of senior unsecured notes due 2028 (the "Notes") in a registered underwritten public offering (the "Offering"). SWK also intends to grant the underwriters of the Offering an option to purchase up to an additional $4.5 million in aggregate principal amount of the Notes. SWK intends to use the net proceeds from the Offering for general corporate purposes, including funding future acquisitions and investments, re
Jul 27, 2023 05:43 pm ET
Stanley Black & Decker Announces 3rd Quarter 2023 Dividend
Board Of Directors Approves Quarterly Cash Dividend Increase To $0.81 Per Share
Jul 17, 2023 04:05 pm ET
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
DALLAS, July 17, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided a corporate progress update as well as a summary of the achievements of its borrower partners. 
Jun 28, 2023 04:05 pm ET
SWK Holdings Corporation Announces New Credit Facility with $45 Million Committed at Close
DALLAS, June 28, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, announced the signing of a new four-year credit facility with First Horizon Bank ("First Horizon"). The four-year facility, which has $45 million committed at close, will bear interest at a rate of SOFR plus 3.75% during the revolving availability period. The facility has an accordion feature that provides for expansion of the facility by up to an incremental $80 million, subject t
May 18, 2023 05:45 am ET
SWK LAWSUIT ALERT: Levi & Korsinsky Notifies Stanley Black & Decker, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, May 18, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Stanley Black & Decker, Inc. ("Stanley" or the "Company") (NYSE: SWK) of a class action securities lawsuit.
May 14, 2023 10:02 pm ET
Stanley Black & Decker, Inc. Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds SWK Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf
RADNOR, Pa., May 14, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Stanley Black & Decker, Inc. ("Stanley") (NYSE: SWK). The action charges Stanley with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects.  As a result of Stanley's materially misleading statements and omissions to the public, Stanley's investors have suffered significant losses.
May 11, 2023 09:00 am ET
White Cap and DEWALT® Partner to Support St. Jude Children's Research Hospital®
$100,000 donation to be made on June 25 at Nashville SuperspeedwayNo. 20 Driver Christopher Bell to wear custom helmet with artwork designed by St. Jude patientsThroughout the month of May, a portion of proceeds from sales of select DEWALT products at U.S. White Cap branches will be donated to St. Jude ATLANTA, May 11, 2023 /PRNewswire/ -- White Cap, a distributor of specialty construction supplies and safety products for professional contractors, and DEWALT®, a Stanley Black & Decker (NYSE: SWK) brand and leader in total jobsite solutions, today announced a charitable partnership to sup
May 11, 2023 07:00 am ET
SWK Holdings Corporation Announces Financial Results for First Quarter 2023
Conference Call and Live Audio Webcast Scheduled for Thursday, May 11, 2023, at 10:00 a.m. ET
May 06, 2023 11:26 am ET
SWK Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Stanley Black & Decker, Inc. and Encourages Investors to
RADNOR, Pa., May 6, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Stanley Black & Decker, Inc. ("Stanley") (NYSE: SWK). The action charges Stanley with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Stanley's materially misleading statements and omissions to the public, Stanley's investors have suffered significant losses.
May 03, 2023 12:45 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stanley Black & Decker, Inc. - SWK
NEW YORK, May 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Stanley Black & Decker, Inc. ("Stanley" or the "Company") (NYSE: SWK). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
May 02, 2023 04:36 pm ET
Stanley Black & Decker Appoints Chris Nelson Chief Operating Officer and Executive Vice President and President of Tools & Outdoor
NEW BRITAIN, Conn., May 2, 2023 /PRNewswire/ -- Stanley Black & Decker (NYSE: SWK) today announced the appointment of Chris Nelson as Chief Operating Officer of the company, and Executive Vice President and President of Tools & Outdoor, effective June 14, 2023. Nelson joins Stanley Black & Decker from Carrier Corporation and brings more than 25 years of leadership experience in general management, product development and innovation, and growth transformation. Nelson will report to Donald Allan Jr., President and CEO of Stanley Black & Decker. He will assume the role of Presid
May 02, 2023 05:45 am ET
SWK ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 23, 2023 in the Class Action Filed on Behalf of Stanley Black & Decker, Inc. Shareholders
NEW YORK, May 2, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Stanley Black & Decker, Inc. (NYSE: SWK) alleging that the Company violated federal securities laws.
Apr 25, 2023 05:45 am ET
SWK ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 23, 2023 in the Class Action Filed on Behalf of Stanley Black & Decker, Inc. Shareholders
NEW YORK, April 25, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Stanley Black & Decker, Inc. (NYSE: SWK) alleging that the Company violated federal securities laws.
Apr 21, 2023 10:50 pm ET
STANLEY BLACK & DECKER SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Stanley Black & Decker, Inc. - SWK
NEW ORLEANS, April 21, 2023 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 23, 2023 to file lead plaintiff applications in a securities class action lawsuit against Stanley Black & Decker, Inc. (NYSE: SWK), if they purchased the Company's shares between October 28, 2021 and July 28, 2022, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Connecticut.
Apr 21, 2023 05:45 am ET
SWK SHAREHOLDER ALERT: Jakubowitz Law Reminds Stanley Shareholders of a Lead Plaintiff Deadline of May 23, 2023
NEW YORK, April 21, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Stanley Black & Decker, Inc. (NYSE: SWK).
Apr 20, 2023 05:45 am ET
SWK LAWSUIT ALERT: Levi & Korsinsky Notifies Stanley Black & Decker, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, April 20, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Stanley Black & Decker, Inc. ("Stanley" or the "Company") (NYSE: SWK) of a class action securities lawsuit.
Apr 17, 2023 01:45 am ET
STANLEY BLACK & DECKER, INC. (NYSE: SWK) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit A
Did you lose money on investments in Stanley Black & Decker?  If so, please visit Stanley Black & Decker, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.                                                                                       
Apr 07, 2023 10:50 pm ET
STANLEY BLACK & DECKER SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Black & Decker, Inc. - SWK
NEW ORLEANS, April 7, 2023 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 23, 2023 to file lead plaintiff applications in a securities class action lawsuit against Stanley Black & Decker, Inc. (NYSE: SWK), if they purchased the Company's shares between October 28, 2021 and July 28, 2022, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Connecticut.
Apr 05, 2023 10:50 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Stanley Black & Decker, Inc. - SWK
CEDARHURST, N.Y., April 5, 2023 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Stanley Black & Decker, Inc. (NYSE: SWK), if they purchased the Company's shares between October 28, 2021 and July 28, 2022, inclusive (the "Class Period").  Shareholders have until May 23, 2023 to file lead plaintiff applications in the securities class action lawsuit.
Apr 03, 2023 07:30 am ET
SWK Holdings Corporation Announces Financial Results for Fourth Quarter and Full Year 2022
Conference Call and Live Audio Webcast Scheduled for Today, April 3, 2023, at 10:00 a.m. ET
Apr 03, 2023 01:45 am ET
STANLEY BLACK & DECKER, INC. (NYSE: SWK) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit A
Did you lose money on investments in Stanley Black & Decker?  If so, please visit Stanley Black & Decker, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.                                                                                       
Mar 31, 2023 08:00 am ET
SWK Holdings Corporation to Report Fourth Quarter and Full-Year 2022 Financial Results
Conference Call and Live Audio Webcast Scheduled for Monday, April 3, 2023, at 10:00 a.m. ET
Mar 20, 2023 02:31 pm ET
SWK INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Stanley Black & Decker, Inc.
NEW YORK, March 20, 2023 /PRNewswire/ -- Levi & Korsinsky notifies investors that it has commenced an investigation of Stanley Black & Decker, Inc. ("Stanley" or the "Company") (NYSE: SWK) concerning possible violations of federal securities laws.
Mar 15, 2023 04:05 pm ET
SWK Holdings Appoints Jerry Albright to Board of Directors
DALLAS, March 15, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that Jerry Albright has been named to the Company's Board of Directors and will replace Wendy DiCicco, who chose not to seek re-election to the Board because of external professional commitments.  The transition will be effective March 15, 2023, with Mr. Albright joining Board Chair, Laurie Dotter, and directors, Robert K. Hatcher, and Marcus Pennington, on the Boa
Jan 31, 2023 07:00 am ET
SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
Fourth Quarter and Full Year 2022 Financial Results to be Announced in March
Jan 12, 2023 08:00 am ET
World of Concrete Debut: DEWALT® To Introduce Revolutionary New Tools, Accessories and Storage for Pros in the Commercial Concrete and Masonry Construction Industries
The DEWALT booth will be located in the Silver Lot at O31168Stop by to be among the first to test and demo DEWALT's newest productsTOWSON, Md., Jan. 12, 2023 /PRNewswire/ -- DEWALT, a Stanley Black & Decker (NYSE: SWK) brand and leader in total jobsite solutions, today announced it will debut several new products supporting the concrete and construction industries at the World of Concrete®† Trade Show in Las Vegas, taking place January 17-19. DEWALT offers concrete professionals a complete line of tools, accessories, anchors, and technology to empower the pros with end-to-end solutions.
Jan 03, 2023 07:35 am ET
SWK Holdings Names Jody Staggs Chief Executive Officer and Appoints Laurie Dotter as Chair of the Board
Mr. Staggs elevated from "interim" to "permanent" CEO as SWK advances multiple initiatives in 2023
Nov 16, 2022 04:15 pm ET
SWK Holdings Corporation Announces Upsizing of Credit Facility up to $50 Million
DALLAS, Nov. 16, 2022 /PRNewswire/ -- SW K Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, announced the signing of the 5th Amendment to the Loan and Security Agreement with Cadence Bank ("Cadence").  The amendment increases Cadence's commitment to $35 million, with a $15 million accordion feature that provides for expansion of the facility up to $50 million, subject to customary conditions. The facility will bear interest at a rate of SOFR plus 2.65% and has a maturity
Nov 15, 2022 07:42 am ET
Branden Irvine Joins sbLiftOff as Director of Sales and Marketing
 Bronze Star Veteran Targets GovCon Businesses Seeking M&A Services
Nov 09, 2022 05:00 pm ET
SWK Holdings Corporation Announces Financial Results for Third Quarter 2022
Conference Call and Live Audio Webcast Scheduled for Thursday, November 10, 2022, at 10:00 a.m. ET
Nov 08, 2022 03:05 pm ET
SWK Holdings Corporation to Report Third Quarter 2022 Financial Results
Conference Call and Live Audio Webcast Scheduled for Thursday, November 10, 2022, at 10:00 a.m. ET
Nov 02, 2022 08:14 am ET
Stanley Black & Decker To Present At The Baird 2022 Industrial Conference
NEW BRITAIN, Conn., Nov. 2, 2022 /PRNewswire/ -- Stanley Black & Decker (NYSE: SWK) invites investors and the general public to listen to a webcast of a presentation by Don Allan, President and CEO, at the Baird 2022 Industrial Conference in Chicago, IL on Wednesday, November 9, 2022 at 9:30 AM ET.
Oct 26, 2022 09:00 am ET
Enteris BioPharma Presents Study of Ovarest® Demonstrating Oral Delivery Comparable to or Exceeding Injectable Leuprolide
Oral Presentation Delivered at the American Society for Reproductive Medicine Scientific (ASRM) 2022 Congress & Expo
Oct 18, 2022 04:05 pm ET
SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
Third Quarter 2022 Financial Results to be Announced in Early November
Oct 10, 2022 04:05 pm ET
SWK Holdings' Subsidiary, Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics
Milestone payment highlights ongoing clinical progress of Oral KORSUVA™
Oct 03, 2022 04:05 pm ET
SWK Holdings Enhances Executive Management Team and Expands Underwriting Team
Yvette Heinrichson promoted to Chief Financial Officer
Sep 12, 2022 08:00 am ET
Enteris BioPharma Publishes White Paper Examining Factors to Consider While Evaluating Oral Administration of Peptides
Physicochemical properties of peptides can provide key insights to potential success of oral delivery
Sep 07, 2022 07:30 am ET
SWK Holdings to Participate in Lake Street Capital's 6th Annual Best Ideas Growth Conference "BIG6"
DALLAS, Sept. 7, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that Jody Staggs, President and Interim CEO of SWK Holdings, will participate in Lake Street Capital's 6th Annual Best Ideas Growth Conference "BIG6" being held September 14, 2022 in New York City.
Sep 01, 2022 07:30 am ET
SWK Holdings Announces Leadership Transition
Jody Staggs appointed as President and Interim CEO
Aug 10, 2022 04:05 pm ET
SWK Holdings Corporation Announces Financial Results for Second Quarter 2022
Conference Call and Live Audio Webcast Scheduled for Thursday, August 11, 2022, at 10:00 a.m. ET
Aug 09, 2022 05:53 pm ET
SWK Holdings Corporation to Report Second Quarter 2022 Financial Results
Conference Call and Live Audio Webcast Scheduled for Thursday, August 11, 2022, at 10:00 a.m. ET
Aug 03, 2022 08:30 am ET
Enteris BioPharma Manufacturing Expertise Highlighted in Drug Development & Delivery Special Feature on Outsourcing Formulation Development & Manufacturing
Article describes Enteris' strengths and scalability in working with highly potent active pharmaceutical ingredients
Jul 14, 2022 08:02 am ET
Enteris BioPharma Announces Acceptance of Abstract for Oral Presentation at ASRM 2022 Scientific Congress & Expo
BOONTON, N.J., July 14, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced today an abstract has been accepted for an oral presentation at the ASRM 2022 Scientific Congress & Expo being held Oct. 22-26, 2022 in Anaheim, Calif The abstract highlights research into the pharmacokinetics of an oral formulation of leuprolide developed utilizing Enteris' proprietary Peptelligence® platform, a novel formulation
Jul 13, 2022 08:00 am ET
SWK Holdings Corporation Marks 10th Anniversary, Celebrating Growth and Progress
Since 2012, SWK Holdings has completed financings with 46 life sciences companies, deploying $650 million of capital
Jun 27, 2022 07:30 am ET
SWK Holdings Corporation Added to Russell 3000® Index, Russell 2000® Index and Russell Microcap® Index
DALLAS, June 27, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science-focused specialty finance company catering to small-and mid-sized commercial-stage companies, announced today its addition to the Russell 2000, Russell 3000 and Russell MicroCap Indexes as part of their annual reconstitution.  SWK's inclusion in the Russell indexes will be effective after the U.S. market opens on Monday, June 27, 2022.
Jun 13, 2022 08:02 am ET
Enteris BioPharma Presents Data from Two Clinical Studies Involving Oral Formulations of Leuprolide at ENDO 2022 Annual Conference
Data suggest that oral formulations of leuprolide developed utilizing Enteris' Peptelligence® platform successfully deliver meaningful circulating drug concentrations and achieve hormonal suppressive effects which are comparable to parenteral administration
Jun 07, 2022 08:33 am ET
Enteris BioPharma Publishes White Paper Examining Safe Handling and Manufacture of Highly Potent Active Pharmaceutical Ingredients (HPAPI)
Facilities and processes key to protecting workers and the environment, the paper in Drug Development & Delivery says
May 26, 2022 08:33 am ET
Enteris Employees Lend Ronald McDonald House a Helping Hand at Enteris Day 2022
BOONTON, N.J., May 26, 2022 /PRNewswire/ --  Enteris BioPharma, Inc. gave plush animals a dose of personality as they created a dozen stuffed teddy bears for Ronald McDonald House Charities to help comfort sick children as they undergo medical treatment.
May 19, 2022 05:48 pm ET
May 11, 2022 06:12 pm ET
/C O R R E C T I O N -- SWK Holdings Corporation/
In the news release, SWK Holdings Corporation Announces Financial Results for First Quarter 2022, issued 11-May-2022 by SWK Holdings Corporation over PR Newswire, we are advised by the company that in the "First Quarter 2022 Financial Results" section, 6th paragraph, last sentence, "Book value per share" changed from "$19.58" to "$21.10" as originally issued inadvertently. The complete, corrected release follows:
May 11, 2022 07:00 am ET
SWK Holdings Corporation Announces Financial Results for First Quarter 2022
Conference Call and Live Audio Webcast Scheduled for Wednesday, May 11, 2022, at 10:00 a.m. ET
May 10, 2022 04:05 pm ET
SWK Holdings Corporation to Report First Quarter 2022 Financial Results
Conference Call and Live Audio Webcast Scheduled for Wednesday, May 11, 2022, at 10:00 a.m. ET
May 04, 2022 08:30 am ET
Enteris BioPharma to Exhibit at CPhI North America 2022
BOONTON, N.J., May 4, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced today that the company will participate in and exhibit at CPhI North America 2022 being held May 17-19, 2022 in Philadelphia (Booth 1708).
Apr 12, 2022 08:02 am ET
Enteris BioPharma Announces Acceptance of Two Abstracts for Presentation at ENDO 2022 Annual Conference
BOONTON, N.J., April 12, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced today that two submitted abstracts were accepted for poster presentations at the 104th annual meeting of The Endocrine Society (ENDO 2022) taking place June 11-14, 2022, in Atlanta, Georgia.  The abstracts highlight research into oral formulations of leuprolide developed utilizing Enteris' proprietary Peptelligence® platform, a novel
Apr 04, 2022 08:03 am ET
Enteris BioPharma Highlighted as Game Changer in Drug Development & Delivery Special Feature on Innovative Technologies for Improving Drug Solubility and Bioavailability
Article describes unique features of Enteris' Peptelligence® and ProPerma® peptide and small molecule oral delivery technology
Mar 28, 2022 07:00 am ET
SWK Holdings Corporation Announces Financial Results for Fourth Quarter and Full-Year 2021
Conference Call and Live Audio Webcast Scheduled for Monday, March 28, 2022, at 10:00 a.m. ET
Mar 25, 2022 08:01 am ET
AOTI Secures Major Expansion Funding from Leading Healthcare Financier
OCEANSIDE, Calif., March 25, 2022 /PRNewswire/ -- Advanced Oxygen Therapy Inc. (AOTI), the global leader in noninvasive topical oxygen wound healing solutions, announced today they have closed a significant round of growth funding from the leading specialist finance company, SWK Holdings Corporation (Nasdaq: SWKH). The funding will support AOTI's ambitious growth plans to expand their market access for TWO2 nationally across the whole USA, as well as building out their clinical support and commercialization platforms, both in the USA and Internationally. AOTI is experiencing rapidly growing
Mar 23, 2022 07:35 am ET
SWK Holdings to Participate in Maxim's 2022 Virtual Growth Conference
DALLAS, March 23, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that Winston Black, Chairman and CEO of SWK Holdings, will deliver a virtual presentation at Maxim's 2022 Virtual Growth Conference being held March 28 – 30, 2022.
Mar 07, 2022 07:01 am ET
Enteris BioPharma Publishes White Paper on Best Practices for Ensuring Content Uniformity in Solid Oral Dosage Manufacturing with HPAPI
BOONTON, N.J., March 7, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced today the publication of a new white paper entitled, "HPAPI Drug Solid Oral Dosage (SOD) Manufacturing – Ensuring Content Uniformity."  
Mar 02, 2022 07:01 am ET
Enteris BioPharma to Participate in DCAT® Week 2022
BOONTON, N.J., March 2, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced today that the company will participate in DCAT® Week 2022 being held March 21-24, 2022 in New York City.
Feb 16, 2022 03:05 pm ET
SWK Holdings Announces Reconstitution of Board of Directors with New Appointments
DALLAS, Feb. 16, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced the reconstitution of the Company's Board of Directors with three new appointments. Effective February 15, 2021, Wendy DiCicco and Robert K. Hatcher were appointed as independent directors, joining, Laurie Dotter, who was appointed as an independent director on February 9, 2022, and previous Board members, Winston Black, Chairman and CEO of SWK Holdings, and Marcus Pennington.
Feb 15, 2022 07:01 am ET
Enteris BioPharma Highlights Progress in Oral Feasibility Program
BOONTON, N.J., Feb. 15, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), provided an update on its oral feasibility programs involving the Company's Peptelligence® and ProPerma® oral peptide and small molecule delivery technologies.
Feb 14, 2022 08:01 am ET
SWK HOLDINGS (SWKH) SHAREHOLDER ALERT – Andrews & Springer LLC Is Investigating SWK Holdings Corporation For Potential Securities Fraud Violations and Breaches of Fiduciary Duty
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential securities violations and breach of fiduciary duty claims against SWK Holdings Corporation (NASDAQCM: SWKH) (“SWK” or the “Company”).
Feb 09, 2022 06:35 am ET
SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
DALLAS, Feb. 9, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, today provided an update on the progress and achievements of its portfolio and partner companies during the second half of 2021 and recent weeks.
Jan 18, 2022 08:07 am ET
SWK HOLDINGS (SWKH) SHAREHOLDER ALERT – Andrews & Springer LLC Is Investigating SWK Holdings Corporation For Potential Securities Fraud Violations and Breaches of Fiduciary Duty
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential securities violations and breach of fiduciary duty claims against SWK Holdings Corporation (NASDAQCM:...
Jan 10, 2022 07:01 am ET
Enteris BioPharma Launches Enhanced Website Showcasing Full Suite of Bench to Market™ Services
BOONTON, N.J., Jan. 10, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced today the launch of its newly enhanced corporate website encapsulating the company's full suite of Bench to Market™ services and its position as the preferred partner for the development and manufacture of oral BCS-III and BCS-IV drug products, including oral peptides, peptidomimetics, and small molecules. The redesigned website may b
Jan 05, 2022 03:53 pm ET
Special Committee Concludes Review of Non-Binding Proposal from Carlson Capital
DALLAS, Jan. 5, 2022 /PRNewswire/ --SWK Holdings Corporation (Nasdaq: SWKH) (the "Company" or "SWK") today announced that the special committee of the Company's board of directors (the "Special Committee") has concluded its investigation of the non-binding proposal received from funds managed by Carlson Capital, L.P. ("Carlson Capital") to acquire all shares of SWK not already owned by Carlson Capital. 
Jan 05, 2022 07:01 am ET
Enteris BioPharma Highlights 2021 Achievements and 2022 Outlook
BOONTON, N.J., Jan. 5, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), provided a review of its 2021 business achievements and development activities as the company anticipates growth opportunities during 2022 involving its industry-leading Peptelligence® and ProPerma® oral peptide and small molecule delivery technologies, and extensive pharmaceutical expertise.
Dec 20, 2021 05:27 pm ET
Dec 20, 2021 07:30 am ET
Enteris BioPharma to Participate in Biotech Showcase Virtual and BIO Partnering at JPM During "J.P. Morgan Week 2022"
BOONTON, N.J., Dec. 20, 2021 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced today that the company is participating in Biotech Showcase Virtual and BIO Partnering at JPM. Both events are scheduled alongside the J.P. Morgan 40th Annual Healthcare Conference 2022.
Dec 09, 2021 04:45 pm ET
SWK Holdings' Subsidiary, Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics
DALLAS, Dec.  9, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that its wholly-owned subsidiary, Enteris BioPharma, received a $5 million milestone payment from Cara Therapeutics (Nasdaq: CARA) related to the license agreement for Peptelligence® oral formulation technology utilized in Oral KORSUVA™, the oral formulation of Cara's first-in-class KOR agonist, CR845/difelikefalin. Enteris is entitled to retain $3.0 million of this payment per the con
Dec 01, 2021 09:38 pm ET
Nov 24, 2021 06:00 am ET
SWK Holdings Confirms Receipt of Non-Binding Proposal from Carlson Capital L.P.
DALLAS, Nov. 24, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) (the "Company" or "SWK") confirmed that on November 23, 2021, it received a non-binding proposal from funds managed by Carlson Capital, L.P. ("Carlson") to acquire all shares of SWK not already owned by Carlson for a price of $19.00 per share, payable in cash. (the "Proposed Acquisition"). This proposal is not related to the prior proposal submitted by Carlson to the Company in April 2021.
Nov 17, 2021 07:01 am ET
Enteris BioPharma Publishes Article Examining the Growing Utilization of the 505(b)(2) Regulatory Pathway in Drug Development
BOONTON, N.J., Nov. 17, 2021 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced today the publication of a new article entitled, "The 505(b)(2) Pathway – Pharma's 'Goldilocks' Opportunity."  
Nov 12, 2021 03:10 pm ET
Nov 01, 2021 07:30 am ET
SWK Holdings Announces Strategic Plan to Focus on Core Specialty Finance Business
DALLAS, Nov. 1, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided an update on the results of the Strategic Review Committee's evaluation of strategic alternatives for the Company.
Oct 26, 2021 08:30 am ET
Enteris BioPharma to Participate in the Partnership Opportunities in Drug Delivery (PODD) 2021 Conference
BOONTON, N.J., Oct. 26, 2021 /PRNewswire/ --Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced today that the company will participate in the Partnership Opportunities in Drug Delivery (PODD) 2021 Conference taking place virtually October 28-29, 2021.
Oct 13, 2021 08:30 am ET
Enteris BioPharma to Participate in the American Association of Pharmaceutical Scientists (AAPS) 2021 PHARMSCI 360 Conference
BOONTON, N.J., Oct. 13, 2021 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced today that the company will participate in the American Association of Pharmaceutical Scientists (AAPS) 2021 PHARMSCI 360 Conference taking place October 17-20, 2021 at the Pennsylvania Convention Center in Philadelphia. This year's meeting includes both in-person and virtual attendance options.
Oct 04, 2021 08:30 am ET
Enteris BioPharma Announces Successful Completion of Phase 1 Clinical Trial of Optimized Peptelligence® Oral Leuprolide
BOONTON, N.J., Oct. 4, 2021 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced the successful completion of a Phase 1 clinical trial investigating its optimized Peptelligence oral tablet formulation of leuprolide.  Data from the 22-patient study indicate that the optimized Peptelligence oral formulation is able to safely deliver a higher dose of leuprolide that enables blood concentrations comparable to subcutane
Aug 23, 2021 08:03 am ET
Enteris BioPharma Receives 2021 Best of Boonton Award
BOONTON, N.J., Aug. 23, 2021 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced that it has received the 2021 Best of Boonton Award in the Pharmaceutical Company category from the Boonton Award Program. This is Enteris' third consecutive Best of Boonton Award, given this year in recognition of the company's continued growth since 2013 from pharmaceutical industry start-up to the industry leader in enabling the or
Aug 16, 2021 04:05 pm ET
Jul 26, 2021 08:05 am ET
Silicon Labs Completes Divestiture of Infrastructure & Automotive Business
AUSTIN, Texas, July 26, 2021 /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB) announced today the completion of the divestiture of its Infrastructure & Automotive business to Skyworks Solutions (NASDAQ: SWKS) for $2.75 billion in an all-cash asset transaction.
Jul 19, 2021 07:33 am ET
SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
DALLAS, July 19, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, today provided an update on the achievements of its portfolio and partner companies during the first half of 2021.
Jun 23, 2021 04:05 pm ET
SWK Holdings Corporation Resumes Share Repurchase Program
DALLAS, June 23, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that its Board of Directors has authorized the Company to repurchase up to an aggregate of $5.0 million of the Company's Common Stock from time to time until March 15, 2022 through a "10b5-1 trading plan" in compliance with Rule 10b-18 under the Securities Exchange Act of 1934. 
Jun 15, 2021 07:35 am ET
Enteris BioPharma to Host Webinar on High Potency Active Pharmaceutical Ingredients in Oral Drug Development
BOONTON, N.J., June 15, 2021 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced that the company will host a webinar, titled, "Key Considerations for HPAPI Oral Drug Product Development." The event is scheduled for Tuesday, June 29, 2021, at 1 p.m. ET, and will be co-hosted by Josh Stephens, Enteris' Sales Manager, Pharmaceutical Drug Delivery, and Angelo Consalvo, Enteris' Director of Manufacturing.
Jun 11, 2021 07:30 am ET
SWK Holdings' Subsidiary, Enteris BioPharma, Receives $10 Million Milestone Payment from Cara Therapeutics
DALLAS, June 11, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that its wholly-owned subsidiary, Enteris BioPharma, received a $10 million milestone payment from Cara Therapeutics (Nasdaq: CARA) related to the license agreement for the Peptelligence® oral formulation technology utilized in Oral KORSUVA™, the oral formulation of Cara's first-in-class KOR agonist, CR845/difelikefalin. Enteris is entitled to retain $3.9 million of this payment per the co
Mar 26, 2021 07:30 am ET
Acerus Announces Amendment to Credit Agreement
Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today announced that it has entered into an amended agreement related to its existing credit facility with SWK Funding LLC (“SWK”), a subsidiary of SWK Holdings...
Feb 16, 2021 07:00 am ET
SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
DALLAS, Feb. 16, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided an update on the progress and achievements of its portfolio and partner companies during the past year.
Jan 12, 2021 07:30 am ET
Enteris BioPharma to Host Webinar on Strategies for Initiating Phase 1 Clinical Development with Limited API
BOONTON, N.J., Jan. 12, 2021 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced that the company will host a webinar, titled "Strategies for Entering Phase 1 Clinical Development with Limited API Quantities."  The event is scheduled for Tuesday, January 19, 2021 at 1:30 p.m., ET, and will be co-hosted by Thomas Daggs, MBA, Enteris' Senior Director Product Development and Quality Control, and Angelo Consalvo, E
Jan 07, 2021 07:00 am ET
Enteris BioPharma Highlights 2020 Achievements and 2021 Outlook
BOONTON, N.J., Jan. 7, 2021 /PRNewswire/ --
Jan 04, 2021 07:07 am ET
Flowonix Medical, Inc. and SWK Holdings Corporation Announce Closing of $33 Million Financing
MOUNT OLIVE, N.J., Jan. 4, 2021 /PRNewswire/ -- Flowonix Medical, Inc., a medical device company focused on providing advanced, implantable drug delivery solutions and SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small and mid-sized commercial-stage companies, announced today that they have closed an approximate $33 million financing. 
Dec 24, 2020 06:30 am ET
SWK Holdings' Subsidiary, Enteris BioPharma, Receives Second Milestone Payment from Cara Therapeutics
DALLAS, Dec. 24, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that its wholly-owned subsidiary, Enteris BioPharma, received a second milestone payment of $2.5 million from Cara Therapeutics (Nasdaq: CARA) related to the license agreement for Peptelligence® oral formulation technology utilized in Oral KORSUVA™, the oral formulation of Cara's first-in-class KOR agonist, CR845/difelikefalin.  SWK is entitled to receive $1.5 million of this payment per t
Dec 17, 2020 07:30 am ET
Enteris BioPharma to Participate in Biotech Showcase Digital and BIO @ JPM During "J.P. Morgan Week 2021"
BOONTON, N.J., Dec. 17, 2020 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced that the company is participating in Biotech Showcase Digital and BIO @ JPM.  Both events will be held virtually and are scheduled alongside the J.P. Morgan 39th Annual Healthcare Conference 2021.
Nov 13, 2020 03:54 pm ET
Nov 11, 2020 06:30 am ET
SWK Holdings Corporation to Participate in A.G.P.'s Virtual Healthcare Symposium
DALLAS, Nov. 11, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer, Winston Black, will participate in A.G.P.'s Virtual Healthcare Symposium on Thursday, November 19, 2020. 
Oct 29, 2020 08:00 am ET
SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
DALLAS, Oct. 29, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today provided an update on the progress and achievements of its portfolio and partner companies during the 2020 calendar year.
Oct 27, 2020 04:05 pm ET
SWK Holdings' Subsidiary, Enteris BioPharma, Receives Milestone Payment from Cara Therapeutics
DALLAS, Oct. 27, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that its wholly-owned subsidiary, Enteris BioPharma, received a milestone payment of $2.5 million from Cara Therapeutics (Nasdaq: CARA) related to the license agreement for Peptelligence® oral formulation technology utilized in Oral KORSUVA™, the oral formulation of Cara's first-in-class KOR agonist, CR845/difelikefalin.  SWK is entitled to receive $1.5 million of this payment per the cont
Sep 28, 2020 08:35 am ET
Financial Services Virtual Investor Conference Presentations Now Available for On-Demand Viewing
NEW YORK, Sept. 28, 2020 /CNW/ - Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Financial Services Conference are now available for on-demand viewing at VirtualInvestorConferences.com.   
Sep 21, 2020 10:10 am ET
OTC Markets Group Announces Agenda for Financial Services Virtual Investor Conference on September 24th
NEW YORK, Sept. 21, 2020 /CNW/ - Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming OTC Financial Services Conference.  Individual investors, institutional investors, advisors and analysts are invited to attend.
Sep 21, 2020 08:35 am ET
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
Life Sciences Investor Forum today announced that the presentations from the September 17th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live company presentations and...
Sep 14, 2020 08:35 am ET
Virtual Conference for Life Sciences Companies Broadcast Live September 17th, 2020
Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and...
Jun 29, 2020 08:35 am ET
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
Life Sciences Investor Forum today announced that the presentations from the June 25th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live company presentations and interactive...
Jun 29, 2020 08:00 am ET
SWK Holdings Corporation Added to Russell 3000® Index, Russell 2000® Index and Russell Microcap® Index
DALLAS, June 29, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, announced today its addition to the broad-market Russell 3000® Index, the Russell 2000® Index and the Russell Microcap® Index in accordance with the 2020 Russell indexes annual reconstitution.  SWK's inclusion in the Russell indexes will be effective after the U.S. market opens on Monday, June 29, 2020.
Jun 23, 2020 04:05 pm ET
SWK Holdings to Webcast Live at Life Sciences Investor Forum
DALLAS, June 23, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, announced today that Chairman and CEO Winston Black will present via webcast at the Life Sciences Investor Forum being held June 25, 2020.
Jun 23, 2020 08:49 am ET
Virtual Conference for Life Sciences Companies Broadcast Live June 25, 2020
Life Sciences Investor Forum today announced the agenda for its second quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company...
Jun 09, 2020 08:33 am ET
Enteris BioPharma Announces Dr. John Vrettos to Participate in BIODURO Webinar Series
BOONTON, N.J., June 9, 2020 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced that John Vrettos, Ph.D., Senior Principal Scientist and Head of Formulation Development at Enteris, has been invited to participate in a webinar series hosted by BIODURO LLC highlighting advances in drug formulation and delivery. Dr. Vrettos will host a presentation, titled "Breaking Through the Barriers of Oral Biologics, on Tuesd
Jun 02, 2020 08:33 am ET
Enteris BioPharma to Participate in BIO International Digital Convention
BOONTON, N.J., June 2, 2020 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced that the company is participating in the BIO International Digital Convention (BIO Digital) being held virtually from June 8-12, 2020.
May 14, 2020 04:05 pm ET
May 04, 2020 08:00 am ET
Enteris BioPharma Appoints Rajiv Khosla, Ph.D., as Chief Executive Officer
BOONTON, N.J., May 4, 2020 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), today announced the hiring of Rajiv Khosla, Ph.D., as Chief Executive Officer, effective immediately.  Dr. Khosla replaces Joel Tune, Enteris' CEO since 2016.
Mar 30, 2020 07:25 pm ET
Mar 26, 2020 08:49 am ET
SWK Holdings Corporation Announces Reauthorization of Share Repurchase Program and Provides Business Update on Coronavirus (COVID-19) Impact
DALLAS, March 26, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small and mid-sized commercial-stage companies, today announced its preliminary revenue and non-GAAP adjusted net income for the fourth quarter and full year ended December 31, 2019.  In addition, SWK Holdings provided an update regarding the evolving impact of the COVID-19 outbreak on the Company's operations and the Company's plans to repurchase its common stock.
Sep 16, 2019 07:30 am ET
SWK Holdings to Present at the Fall Investor Summit
DALLAS, Sept. 16, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, announced that CEO Winston Black will present at the Fall Investor Summit being held today in New York City.
Sep 06, 2019 08:00 am ET
SWK Holdings Corporation Resumes Share Repurchase Program
DALLAS, Sept. 6, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, today announced that its Board of Directors has authorized the Company to repurchase up to an aggregate of $2.1 million of the Company's Common Stock from time to time until February 29, 2020 through a "10b5-1 trading plan" in compliance with Rule 10b-18 under the Securities Exchange Act of 1934.  The amount approved in the repurchase plan represents the balance of the $3.5 million stock repurchase program that had not been repurchased by its ex
Sep 03, 2019 08:02 am ET
SWK Holdings Corporation Files Application for Uplisting to NASDAQ Capital Market
DALLAS, Sept. 3, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, announced today that the Company has submitted its formal application to list its common shares on the NASDAQ Capital Market.
Aug 27, 2019 08:30 am ET
SWK Holdings Corporation Acquires Enteris BioPharma
DALLAS and BOONTON, N.J., Aug. 27, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, and Enteris BioPharma, Inc. ("Enteris"), a biotechnology company offering innovative formulation solutions utilizing its proprietary oral drug delivery technology, Peptelligence®, announced today a strategic acquisition whereby SWK, through its wholly-owned subsidiary, SWK Acquisition Corporation, has acquired 100% of Enteris' equity from Victory Park Capital ("Seller"). 
Aug 12, 2019 06:59 pm ET
SWK Holdings Corporation Announces 2019 Second Quarter Financial Results
SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its second quarter 2019 financial results. Second Quarter 2019 Highlights: Reported total revenues of $5.7 million for the...
May 29, 2019 07:00 am ET
Harrow Health Announces Renegotiated Debt Facility with SWK Holdings
Harrow Health, Inc. (NASDAQ: HROW) today announced it has amended its loan agreement with SWK Funding LLC and its partners.  SWK Funding LLC is a subsidiary of SWK Holdings Corporation, a healthcare-focused investment firm. Under the amended...
May 15, 2019 09:28 pm ET
SWK Holdings Corporation Announces 2019 First Quarter Financial Results
SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its first quarter 2019 financial results. First Quarter 2019 Highlights: Reported total revenues of approximately $9.4...
Mar 29, 2019 09:20 am ET
SWK Holdings Corporation Announces 2018 Fourth Quarter and Full-Year Financial Results
SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its fourth quarter and full year 2018 financial results. Fourth Quarter 2018 Highlights: Reported total revenues of...
Dec 06, 2018 05:09 pm ET
SWK Holdings Corporation Announces Share Repurchase Program
SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, today announced that its Board of Directors has authorized the Company to repurchase up to an aggregate of $3,500,000 of the Company’s...
Nov 12, 2018 05:46 pm ET
SWK Holdings Corporation Announces 2018 Third Quarter Financial Results
SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its third quarter 2018 financial results. Third Quarter 2018 Highlights: Reported total revenues of approximately $5.9...
Aug 10, 2018 05:47 pm ET
SWK Holdings Corporation Announces 2018 Second Quarter Financial Results
SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its second quarter 2018 financial results. Second Quarter 2018 Highlights: Reported total revenues of...
Jul 02, 2018 09:00 am ET
SWK Holdings Corporation Closes $20 Million Revolving Loan Facility with AloStar Capital Finance
SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced that it has closed a $20 million revolving credit facility with AloStar Capital Finance, a division of State Bank Trust...
May 15, 2018 08:40 am ET
SWK Holdings Corporation Announces 2018 First Quarter Financial Results
SWK Holdings Corporation (OTC:SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its first quarter 2018 financial results. First Quarter 2018 Highlights: Reported total revenues of $6.8 million for the...
Mar 29, 2018 05:38 pm ET
SWK Holdings Corporation Announces 2017 Fourth Quarter and Full-Year Financial Results
•         Total revenues of $37.5 million for the fiscal year 2017 compared to $22.4 million for the fiscal year 2016.
Nov 10, 2017 08:49 am ET
SWK Holdings Corporation Announces 2017 Third Quarter Financial Results
DALLAS, Nov. 10, 2017 (GLOBE NEWSWIRE) -- SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its third quarter 2017 financial results.
Aug 10, 2017 04:01 pm ET
SWK Holdings Corporation Announces 2017 Second Quarter Financial Results
 Total revenues of approximately $6.1 million for the second quarter of 2017 compared to $8.6 million for the second quarter of 2016. Net income attributable to SWK Shareholders of $3.4 million, or $0.26 per share, and non-GAAP Adjusted net income of $5.0 million, or $0.38 per share for the second quarter of 2017. Post quarter’s end, closed two financings deploying $17.2 million with additional $6.6 million deployed through existing portfolio company milestones and add-ons.    Book value of $16.47 per share as of June 30, 2017 vs. $15.67 per share as of December 31, 2016.  DALLAS, Texas, Aug....
Jul 20, 2017 09:00 am ET
Imprimis Pharmaceuticals Announces $16 Million Debt Facility with SWK Holdings
SAN DIEGO, July 20, 2017 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmology-focused pharmaceutical company, today announced it has entered into a $16 million senior secured non-dilutive term loan agreement with SWK Funding LLC and its partners. SWK Funding LLC is a subsidiary of SWK Holdings Corporation, a healthcare focused investment firm. The company plans to use the proceeds to retire its existing $13 million term loan with an affiliate of Life Sciences Alternative Funding LLC, and provide additional working capital for its growing ophthalmic formulation pipe
Nov 08, 2016 05:00 pm ET
SWK Holdings Corporation Announces 2016 Third Quarter Financial Results
Total revenues of $4.2 million for the third quarter of 2016 compared to $5.7 million for the third quarter of 2015For the third quarter of 2016 net income attributable to SWK Shareholders of $3.1 million, or $0.24 per share, and non-GAAP adjusted net income of $2.6 million, or $0.20 per shareFor the first-nine months of 2016 net income attributable to SWK Shareholders of $5.2 million, or $0.39 per share, and non-GAAP adjusted net income of $4.2 million, or $0.32 per shareTotal income producing assets (defined as finance receivables, marketable investments and investment in unconsolidated en...
Aug 10, 2016 04:02 pm ET
SWK Holdings Corporation Announces 2016 Second Quarter Financial Results
Total revenues of $8.6 million for the three months ended June 2016 compared to $5.4 million for the second quarter of 2015  For the three months ended June 2016 net loss attributable to SWK Shareholders of $1.0 million, or $0.08 per share, and non-GAAP adjusted net loss of $0.6 million, or $0.04 per share For the six months ended June 2016 net income attributable to SWK Shareholders of $2.1 million, or $0.16 per share, and non-GAAP adjusted net income of $2.5 million, or $0.19 per share Total income producing assets (defined as finance receivables, marketable securities and investment in un...
May 13, 2016 04:29 pm ET
SWK Holdings Corporation Announces 2016 First Quarter Financial Results
Total revenues of approximately $5.2 million for the first quarter of 2016.  Net income attributable to SWK Shareholders of $3.1 million, or $0.24 per share, and non-GAAP Adjusted net income of $3.1 million, or $0.24 per share. Book value of $13.71 per share as of March 31, 2016. DALLAS, May 13, 2016 (GLOBE NEWSWIRE) -- SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its first quarter 2016 financial results....

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.